Merrimack Pharmaceuticals (MACK) Earnings

May 12Confirmed
Aug 2021
Nov 2021
Mar 2022
May 2022
-0.67
-0.34
-0
0.33

Details

Expected EPS
N/A
Actual EPS
-0.67
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Merrimack Pharmaceuticals⁩ (⁦MACK⁩) has reported earnings of ⁦-0.67⁩ per share for ⁦null⁩.

0 Comments

Share your thoughts